IRB Approval for Saliva Multi-Omics Discovery, Detection, & Diagnostic Innovation

PRESS RELEASE
Leslie Titus Bryant
May 25, 2022

SALT LAKE CITY, UTAH—Spectrum Solutions, LLC today announced its medical science division has received independent institutional review board (IRB) approval from Sterling IRB to drive saliva-based multi-omic discovery, detection, and diagnostic innovation. This broad-reaching IRB clearance highlights a focus on noninvasive molecular diagnostic and antigen-based multiplex RT-PCR testing using human saliva collected, stabilized, and amplified with the Spectrum saliva self-collection system under the direction of principal investigator and Spectrum’s Chief Science Officer, David J Vigerust, Ph.D.

At the start of the pandemic, Spectrum Solutions was the first to push the boundaries of discovery and expand the nation’s diagnostic awareness to a safer option using saliva. As a result, Spectrum’s noninvasive saliva self-collection innovation was the first to receive FDA Emergency Use Authorization (EUA) for saliva-based COVID-19 testing. The vast benefits of this advance in clinical diagnostic healthcare using saliva continue to reach across the multiverse of omics and ologies impacting patient outcomes worldwide.

“We are excited to see testing service providers, medical facilities, and laboratories around the globe embracing and favoring saliva-based testing using Spectrum’s innovation for its unparalleled ease-of-use and safety,” said Rohit Gupta, Chief Medical Officer at Spectrum Solutions.

Among others, this study highlights two key elements to advancing, modernizing, and safely managing remote care. First, the early detection and in-device neutralization of multiple pathogens in a single saliva test, and second, the importance of consistent, robust post-collection sample stability at ambient temperatures offering stress-free storage and extended transport solutions.

Are you interested in learning more about integrating saliva into your current research or testing programs? Click here to find out more about Saliva Collection Multi-Omic Innovation.

> Read this release on the BusinessWire.com

IRB Approval for Saliva Multi-Omics Discovery, Detection, & Diagnostic Innovation

PRESS RELEASE
Leslie Titus Bryant
May 25, 2022

SALT LAKE CITY, UTAH—Spectrum Solutions, LLC today announced its medical science division has received independent institutional review board (IRB) approval from Sterling IRB to drive saliva-based multi-omic discovery, detection, and diagnostic innovation. This broad-reaching IRB clearance highlights a focus on noninvasive molecular diagnostic and antigen-based multiplex RT-PCR testing using human saliva collected, stabilized, and amplified with the Spectrum saliva self-collection system under the direction of principal investigator and Spectrum’s Chief Science Officer, David J Vigerust, Ph.D.

At the start of the pandemic, Spectrum Solutions was the first to push the boundaries of discovery and expand the nation’s diagnostic awareness to a safer option using saliva. As a result, Spectrum’s noninvasive saliva self-collection innovation was the first to receive FDA Emergency Use Authorization (EUA) for saliva-based COVID-19 testing. The vast benefits of this advance in clinical diagnostic healthcare using saliva continue to reach across the multiverse of omics and ologies impacting patient outcomes worldwide.

“We are excited to see testing service providers, medical facilities, and laboratories around the globe embracing and favoring saliva-based testing using Spectrum’s innovation for its unparalleled ease-of-use and safety,” said Rohit Gupta, Chief Medical Officer at Spectrum Solutions.

Among others, this study highlights two key elements to advancing, modernizing, and safely managing remote care. First, the early detection and in-device neutralization of multiple pathogens in a single saliva test, and second, the importance of consistent, robust post-collection sample stability at ambient temperatures offering stress-free storage and extended transport solutions.

>Read this release on the BusinessWire.com

Major League Baseball Logo

Bringing Baseball Back!

How you collect saliva makes a big difference

Increase workplace safety and build team confidence with simple and safe repeat testing programs supporting 100% accurate early detection and easy direct-to-user at-home options. Just ask Major League Baseball. See how our saliva collection system is credited for bringing baseball back” and making Salt Lake “the league’s most important city”.

™/© 2020 MLB

Major League Baseball Logo

Bringing Baseball Back!

How you collect saliva makes a big difference

Increase workplace safety and build team confidence with simple and safe repeat testing programs supporting 100% accurate early detection and easy direct-to-user at-home options. Just ask the Major League Baseball. See how our saliva collection system is credited for bringing baseball back” and making Salt Lake “the league’s most important city”.

™/© 2020 MLB

About Spectrum Solutions®

Headquartered in Salt Lake City, Utah, Spectrum Solutions is dedicated to empowering complete wellness and bridging the gap between science and innovative healthcare solutions. Our stand-alone and fully integrated test-to-treat solutions support molecular diagnostics and DTC testing applications, advancing product development and accelerating go-to-market applications. Our single-source, end-to-end capabilities include a CAP/CLIA accredited molecular diagnostic laboratory, onsite compounding pharmacy, medical and non-medical product development, manufacturing, and fulfillment.

#partoftheSolution

Leslie Titus Bryant Spectrum Solutions SpokesmanSpectrum Corporate Spokesman
Leslie Titus Bryant
Head of Marketing & Brand
admin@spectrumsolution.com

Tim Rush Public Relations, Springboard 5Media Contact
Tim Rush, Springboard5
801-208-1100
tim.rush@springboard5.com

About Spectrum Solutions®

Headquartered in Salt Lake City, Utah, Spectrum Solutions is dedicated to empowering complete wellness and bridging the gap between science and innovative healthcare solutions. Our stand-alone and fully integrated test-to-treat solutions support molecular diagnostics and DTC testing applications, advancing product development and accelerating go-to-market applications. Our single-source, end-to-end capabilities include a CAP/CLIA accredited molecular diagnostic laboratory, onsite compounding pharmacy, medical and non-medical product development, manufacturing, and fulfillment.

#partoftheSolution

Leslie Titus Bryant Spectrum Solutions SpokesmanSpectrum Corporate Spokesman
Leslie Titus Bryant
Head of Marketing & Brand
admin@spectrumsolution.com

Tim Rush Public Relations, Springboard 5Media Contact
Tim Rush, Springboard5
801-208-1100
tim.rush@springboard5.com

We'd Love to Connect

#SpitMatters

We'd Love to Connect

#SpitMatters

2023-12-15T04:32:40+00:00
Go to Top